| Filed On | Filing |
|---|---|
| 20 Mar 2026 |
Form 3: Uppaluri Subbarao V, Director
Holds 622,817 shares of Common Stock |
| 11 May 2022 |
Form 3: Nabel Gary J., Director
Holds 0 shares of Common Stock |
| 11 May 2022 |
Form 3: Zerhouni Elias A., Director
Holds 0 shares of Common Stock |
| 11 May 2022 |
Form 3: Borisy Alexis, Director
Holds 0 shares of Common Stock |
| 09 May 2022 |
Form 3: Opko HEALTH, Inc., 10% owner · GeneDx Holdings Corp.
Holds 80,000,000 shares of Class A Common Stock, par value $0.0001 per share |
| 03 Mar 2021 |
Form 3: Lachman Prem A, Director
Holds 0 shares of Common Stock |
| 21 Dec 2020 |
Form 3: Medel Roger Md, Director
No securities owned |
| 24 Jul 2020 |
Form 3: Hernandez Rulfo Fernando, CAO, Treasurer
Holds 87 shares of Common Stock |
| 24 Jul 2020 |
Form 3: Cohen Jon R, Director
Holds 75,000 shares of Common Stock |
| 08 Jan 2020 |
Form 3: Japour Anthony J, Director
No securities owned |
| 04 Apr 2018 |
Form 3: Fishel Robert Scott, Director
Holds 4,001,428 shares of Common Stock |
| 09 Nov 2017 |
Form 3: Opko Health, Inc., 10% owner · VBI Vaccines Inc/BC
Holds 6,023,014 shares of Common Stock |
| 04 Aug 2017 |
Form 3: Opko Health, Inc., 10% owner · Eloxx Pharmaceuticals Inc
Holds 10,517,016 shares of Common Stock |
| 10 Feb 2017 |
Form 3: Krasno Richard M, Director
Holds 73,333 shares of Common Stock |
| 17 Mar 2014 |
Form 3: Opko Health, Inc., 10% owner · Cocrystal Pharma Inc
Holds 18,696,301 shares of Common Stock |
| 13 Mar 2013 |
Form 3: Opko Health, Inc., 10% owner · Phio Pharmaceuticals Corp
Holds 67,241,380 shares of Common Stock |
| 18 Jul 2012 |
Form 3: Rodriguez Juan F, Sr. Vice President, CFO
No securities owned |
| 15 Jun 2012 |
Form 3: Kolosov Dmitry, Director
No securities owned |
| 22 Sep 2009 |
Form 3: Opko Health, Inc., 10% owner · Sorrento Therapeutics, Inc.
Holds 59,015,257 shares of Common Stock |
| 23 Apr 2009 |
Form 3: Yu Alice Lin-Tsing, Director
No securities owned |
Loading...